Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes In Stockholders' Equity (Unaudited)

v3.21.2
Condensed Consolidated Statements of Changes In Stockholders' Equity (Unaudited) - USD ($)
Series H Preferred Stock [Member]
Preferred Stock [Member]
Series H-3 Preferred Stock [Member]
Preferred Stock [Member]
Series H-6 Preferred Stock [Member]
Preferred Stock [Member]
Series Seed Preferred Stock [Member]
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2019     $ 9,025,245 $ 395 $ 5,001,947 $ (13,958,644) $ 68,943
Balance, shares at Dec. 31, 2019 7,360,985 3,948,078      
Stock Based Compensation           156,459   156,459
Net Loss   (1,795,153) (1,795,153)
Ending balance, value at Mar. 31, 2020 $ 9,025,245 $ 395 5,158,406 (15,753,797) (1,569,751)
Balance, shares at Mar. 31, 2020 7,360,985 3,948,078      
Beginning balance, value at Dec. 31, 2019     $ 9,025,245 $ 395 5,001,947 (13,958,644) 68,943
Balance, shares at Dec. 31, 2019 7,360,985 3,948,078      
Net Loss               (6,006,735)
Ending balance, value at Sep. 30, 2020 $ 2,430 51,156,135 (20,398,106) 30,760,459
Balance, shares at Sep. 30, 2020 8 2,189 50 24,298,333      
Beginning balance, value at Dec. 31, 2019     $ 9,025,245 $ 395 5,001,947 (13,958,644) 68,943
Balance, shares at Dec. 31, 2019 7,360,985 3,948,078      
Conversion of ayro preferred stock to common stock, shares   955            
Ending balance, value at Dec. 31, 2020 $ 2,709 64,509,724 (25,154,817) 39,357,616
Balance, shares at Dec. 31, 2020 8 1,234 50   27,088,584      
Beginning balance, value at Mar. 31, 2020 $ 9,025,245 $ 395 5,158,406 (15,753,797) (1,569,751)
Balance, shares at Mar. 31, 2020 7,360,985 3,948,078      
Conversion of AYRO Preferred Stock to common stock       $ (9,025,245) $ 201 9,025,044  
Conversion of ayro preferred stock to common stock, shares       (7,360,985) 2,007,193      
Issuance of Series H Preferred Stock in connection with the 2020 Merger            
Issuance of series h preferred stock in connection with the 2020 merger, shares 8              
Issuance of Series H-3 Preferred Stock in connection with the 2020 Merger            
Issuance of series h-3 preferred stock in connection with the 2020 merger, shares   2,189            
Issuance of Series H-6 Preferred Stock in connection with the 2020 Merger            
Issuance of series h-6 preferred stock in connection with the 2020 merger, shares     7,883          
Issuance of Common Stock in connection with the 2020 Merger, net of fees         $ 493 4,451,237   4,451,730
Issuance of common stock in connection with the 2020 merger, net of fees, shares         4,939,045      
Exchange of debt for common stock in connection with the 2020 Merger         $ 103 999,897   1,000,000
Exchange of debt for common stock in connection with the 2020 merger, shares         1,030,585      
Issuance of common stock in connection with debt offering         $ 56 461,957   462,013
Issuance of common stock in connection with debt offering, shares         553,330      
Exercise of warrants, net of fees         $ 183 515,155   515,338
Exercise of warrants, net of fees, shares         1,831,733      
Stock Based Compensation           150,949   150,949
Sale of common stock, net of fees         $ 220 5,064,780   5,065,000
Sale of common stock, net of fees, shares         2,200,000      
Net Loss             (1,530,856) (1,530,856)
Ending balance, value at Jun. 30, 2020 $ 1,651 25,827,425 (17,284,653) 8,544,423
Balance, shares at Jun. 30, 2020 8.00 2,189.00 7,883.00 16,509,964      
Exercise of warrants, net of fees         $ 254 2,467,936   2,468,190
Exercise of warrants, net of fees, shares         2,539,769      
Conversion of Series H-6 Preferred Stock         $ 23 (23)  
Conversion of series h-6 preferred stock, shares     (7,833.00)   225,590      
Stock Based Compensation           119,853   119,853
Sale of common stock, net of fees         $ 500 22,260,302   22,260,802
Sale of common stock, net of fees, shares         5,007,895      
Vested Restricted Stock         $ 2 47,915   47,917
Vested restricted stock, shares         15,115      
Deemed Dividend on modification of H-5 warrants           432,727 (432,727)
Net Loss     (2,680,726) (2,680,726)
Ending balance, value at Sep. 30, 2020 $ 2,430 51,156,135 (20,398,106) 30,760,459
Balance, shares at Sep. 30, 2020 8 2,189 50 24,298,333      
Beginning balance, value at Dec. 31, 2020 $ 2,709 64,509,724 (25,154,817) 39,357,616
Balance, shares at Dec. 31, 2020 8 1,234 50   27,088,584      
Stock Based Compensation           1,699,423   1,699,423
Sale of common stock, net of fees         $ 804 58,269,025   58,269,829
Sale of common stock, net of fees, shares         8,035,835      
Exercise of Warrants       $ 1 99,999   100,000
Exercise of warrants, shares         13,642      
Exercise of Options         $ 7 183,418   183,425
Exercise of options, shares         74,987      
Net Loss     (5,633,833) (5,633,833)
Ending balance, value at Mar. 31, 2021 $ 3,521 124,761,589 (30,788,650) 93,976,460
Balance, shares at Mar. 31, 2021 8 1,234 50   35,213,048      
Beginning balance, value at Dec. 31, 2020 $ 2,709 64,509,724 (25,154,817) $ 39,357,616
Balance, shares at Dec. 31, 2020 8 1,234 50   27,088,584      
Exercise of options, shares               555,004
Net Loss               $ (25,299,657)
Ending balance, value at Sep. 30, 2021 $ 3,643 128,777,533 (50,454,474) 78,326,702
Balance, shares at Sep. 30, 2021 8 1,234 50   36,432,789      
Beginning balance, value at Mar. 31, 2021 $ 3,521 124,761,589 (30,788,650) 93,976,460
Balance, shares at Mar. 31, 2021 8 1,234 50   35,213,048      
Issuance of common stock for services         $ 2 42,298   42,300
Issuance of common stock for services, shares         15,000      
Stock Based Compensation           1,638,071   1,638,071
Exercise of Options         $ 39 1,041,452   1,041,491
Exercise of options, shares         394,589      
Vested Restricted Stock         $ 68 (68)   0
Vested restricted stock, shares         681,725      
Net Loss     (7,663,749) (7,663,749)
Ending balance, value at Jun. 30, 2021 $ 3,630 127,483,342 (38,452,399) 89,034,573
Balance, shares at Jun. 30, 2021 8 1,234 50   36,304,362      
Stock Based Compensation           1,012,121   1,012,121
Exercise of Options         $ 9 282,074   282,083
Exercise of options, shares         85,428      
Vested Restricted Stock         $ 4 (4)   0
Vested restricted stock, shares         42,999      
Net Loss     (12,002,075) (12,002,075)
Ending balance, value at Sep. 30, 2021 $ 3,643 $ 128,777,533 $ (50,454,474) $ 78,326,702
Balance, shares at Sep. 30, 2021 8 1,234 50   36,432,789